Biggest News Aggregation in the World
📰 Image Database News

Page 2 - Image Database News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Image Database. Real-time updates on events, politics, business and more.

New Patent Public Search Tool and Webpage from USPTO

On February 1, 2022, the US Patent and Trademark Office announced a new Patent Public Search tool similar to the search tools used by patent examiners to provide more convenient and robust full-text searching of all US patents and published patent applications.
Trademark Office Trademark Resource Center Patent Public Search Patents End To Automated Search Tool Public Web Based Examiner

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Neues Wanderbuch der Tourismus Siebengebirge GmbH: Elf Rundwege zum Flanieren

Neues Wanderbuch der Tourismus Siebengebirge GmbH: Elf Rundwege zum Flanieren Neues Wanderbuch der Tourismus Siebengebirge GmbH : Elf Rundwege zum Flanieren Nicht nur in der Region ein Begriff: Drachenfels und Schloss Drachenburg gehören zu den Wahrzeichen des Siebengebirges. Foto: Frank Homann Von Roswitha Oschmann Carl Spitzweg dichtete im 19. Jahrhundert: „Wenn dir’s vergönnt je, dann richt es so ...
Czech Republic Rheinland Pfalz Nordrhein Westfalen Dragon Castle Tourism Seven Mountains Gmbh Stroll Not
Source: ga.de

Population of Patents at Risk from Proposed WTO Patent Waiver | McDonnell Boehnen Hulbert & Berghoff LLP

Dennis Crouch, our colleague at Patently-O, tweeted last week that there have been 148 U.S. patents granted having disclosure related to (COVID-19 or SARS-CoV-2); With regard to issues involving the proposed WTO IP waiver ( see "If the Devil of the WTO IP Waiver Is in the Details, What Are the Details?"), it may be instructive to inspect the relatively few (4) of these patents directed to COVID-19 specific vaccines (another 4 were directed to therapeutic antibodies).  These are set forth in...
Dennis Crouch Mcdonnell Boehnen Hulbert Berghoff Tillis Asks Biden Administration To Oppose Drug Administration Trademark Office Patent Mcdonnell Boehnen Hulbert

A Heightened Bar: Federal Circuit Leaves Functional Antibody Claims on Thin Ice | Rothwell, Figg, Ernst & Manbeck, P.C.

Amgen Inc. et al. v. Sanofi, Aventisub LLC, et al., No. 20-1074 (Fed. Cir. 2021) issued on February 11, 2021, the Federal Circuit affirmed the decision of the United States District Court for the District of Delaware granting JMOL that Amgen’s Repatha® patents (U.S. Patent Nos. 8,829,165 and 8,859,741) were invalid for lack of enablement. The district court’s grant of JMOL overturned a jury verdict finding Amgen’s claims were not invalid for lack of enablement. The claims at issue cover ...
United States Amgen Repatha Enzo Life Sciences Inc While The Court Idenix Pharmaceuticals United States District Court

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science